Adding the antiangiogenic drug to standard care does not extend overall survival among patients with metastatic esophageal ...

Bollywood actor Tannishtha Chatterjee revealed her Stage 4 oligometastatic cancer diagnosis, a lesser-known advanced form ...

Acclaimed actress Tannishtha Chatterjee bravely shared her ongoing battle with Stage 4 cancer, revealing how the diagnosis ...

Scars, flat chests and strength took center stage as women living with breast cancer turned the Cancer Culture X AnaOno ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

Chinese researchers have revealed a mechanism that triggers metastasis of hepatocellular carcinoma (HCC)—the most common type ...

The decision by the Canadian regulator is supported by the findings from the Phase III DESTINY-Breast06 study.

An investigator presented results from a pre-specified primary efficacy analysis of the phase 2 EXTEND trial testing the progression-free survival (PFS) benefits of metastasis-directed therapy by ...

BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...

By the time of the diagnosis, his entire body from the chest down was completely paralysed – and he has now been told it is ...

ADC usage in breast cancer treatment increased 3.7-fold from 2021 to 2023, with significant reductions in median time to ...

Sacituzumab tirumotecan (sac-TMT) significantly improved progression-free survival compared to chemotherapy in HR-positive, ...